Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03957239 · ClinicalTrials.gov registry record · NA
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
A NA study of Intestinal Permeability and Gastrointestinal Function, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT03957239: Completed NA study of Intestinal Permeability and Gastrointestinal Function, sponsored by University of Florida.
NCT03957239 is a NA study of Intestinal Permeability and Gastrointestinal Function that has completed, run by University of Florida. The registered enrollment target is 43 participants, below the 51-participant average among 3 other Intestinal Permeability trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03957239, a NA study of Intestinal Permeability and Gastrointestinal Function, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
In this double blind, crossover study participants will consume a cranberry beverage and a cranberry-flavored beverage for 2 weeks each. Gut permeability will be assessed weekly using aspirin and food-grade sugar molecules. Participants will be asked to provide urine, blood, saliva and stool samples to assess gut permeability and microbial communities. No change in permeability to the small sugar probes is anticipated with the cranberry beverage
Primary Outcome
Compare the statistical difference between the change from baseline (i.e., final - baseline) in gastroduodenal permeability after consuming the cranberry beverage for 2 weeks versus the change after consuming the control beverage for 2 weeks. Gastroduodenal permeability will be assessed following aspirin challenge by measuring urinary sucrose in the 0 to 5-hour urine collection.
Conditions Studied
Interventions
- OTHER Control Beverage
- OTHER Cranberry Beverage
Study Locations (1)
Florida
- UF Health at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-09-05 |
| Est. Completion | 2020-01-02 |
| Phase | NA |
What the finished NCT03957239 record still lists
NCT03957239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 51-participant average among 3 other Intestinal Permeability trials with a reported enrollment target (16% lower).
The record links to 2 conditions, with Intestinal Permeability appearing as the primary indexed condition, and to 2 interventions - of which Control Beverage is the first listed.
NCT03957239 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03957239 about?
NCT03957239 is a clinical study titled "The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults". In this double blind, crossover study participants will consume a cranberry beverage and a cranberry-flavored beverage for 2 weeks each. Gut permeability will be assessed weekly using aspirin and food-grade sugar molecules. Participants will be asked to provide urine, blood, saliva and stool samples...
What is the current status of trial NCT03957239?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-09-05. Estimated completion is 2020-01-02.
What conditions does trial NCT03957239 study?
This clinical trial studies the following conditions: Intestinal Permeability, Gastrointestinal Function.
What interventions are being tested in trial NCT03957239?
The interventions under investigation include: Control Beverage (OTHER), Cranberry Beverage (OTHER).
Who is sponsoring clinical trial NCT03957239?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03957239 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intestinal Permeability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI